{"AllianceGenome": "7967", "HGNC": "7967", "MIM": "603826", "_id": "9971", "_version": 1, "accession": {"genomic": ["AC010200.8", "AY245533.1", "CH471054.1", "CP068266.2", "KT585226.1", "NC_000012.12", "NC_060936.1", "NG_029843.1"], "protein": ["AAB08107.1", "AAH71778.1", "AAI30574.1", "AAI44185.1", "AAK60271.1", "AAM53550.1", "AAM53551.1", "ADZ17382.1", "BAG35798.1", "BAH02290.1", "BAH12398.1", "BAH12409.1", "CAE11874.2", "EAW97638.1", "EAW97639.1", "EAW97640.1", "NP_001193906.1", "NP_001193907.1", "NP_001193908.1", "NP_001193921.1", "NP_001193922.1", "NP_005114.1", "Q96RI1.2", "XP_006719782.1", "XP_011537342.1", "XP_011537343.1", "XP_047285899.1", "XP_047285900.1", "XP_054229928.1", "XP_054229929.1", "XP_054229930.1", "XP_054229931.1", "XP_054229932.1"], "rna": ["AB307699.1", "AF384555.1", "AF478445.1", "AF478446.1", "AK296612.1", "AK296647.1", "AK312959.1", "BC035654.1", "BC071778.1", "BC130573.1", "BC144183.1", "BC144184.1", "BC144187.1", "BX571749.1", "DA011411.1", "DA016827.1", "HQ709175.1", "NM_001206977.2", "NM_001206978.2", "NM_001206979.2", "NM_001206992.2", "NM_001206993.2", "NM_005123.4", "NR_135146.2", "U68233.1", "XM_006719719.3", "XM_011539040.3", "XM_011539041.3", "XM_047429943.1", "XM_047429944.1", "XM_054373953.1", "XM_054373954.1", "XM_054373955.1", "XM_054373956.1", "XM_054373957.1"], "translation": [{"protein": "XP_006719782.1", "rna": "XM_006719719.3"}, {"protein": "AAM53551.1", "rna": "AF478446.1"}, {"protein": "XP_011537342.1", "rna": "XM_011539040.3"}, {"protein": "XP_054229928.1", "rna": "XM_054373953.1"}, {"protein": "BAG35798.1", "rna": "AK312959.1"}, {"protein": "XP_054229930.1", "rna": "XM_054373955.1"}, {"protein": "CAE11874.2", "rna": "BX571749.1"}, {"protein": "XP_011537343.1", "rna": "XM_011539041.3"}, {"protein": "AAB08107.1", "rna": "U68233.1"}, {"protein": "XP_054229932.1", "rna": "XM_054373957.1"}, {"protein": "NP_005114.1", "rna": "NM_005123.4"}, {"protein": "ADZ17382.1", "rna": "HQ709175.1"}, {"protein": "BAH02290.1", "rna": "AB307699.1"}, {"protein": "BAH12409.1", "rna": "AK296647.1"}, {"protein": "NP_001193922.1", "rna": "NM_001206993.2"}, {"protein": "AAI30574.1", "rna": "BC130573.1"}, {"protein": "BAH12398.1", "rna": "AK296612.1"}, {"protein": "NP_001193921.1", "rna": "NM_001206992.2"}, {"protein": "AAK60271.1", "rna": "AF384555.1"}, {"protein": "XP_054229931.1", "rna": "XM_054373956.1"}, {"protein": "AAI44185.1", "rna": "BC144184.1"}, {"protein": "XP_054229929.1", "rna": "XM_054373954.1"}, {"protein": "XP_047285900.1", "rna": "XM_047429944.1"}, {"protein": "AAH71778.1", "rna": "BC071778.1"}, {"protein": "XP_047285899.1", "rna": "XM_047429943.1"}, {"protein": "NP_001193908.1", "rna": "NM_001206979.2"}, {"protein": "AAM53550.1", "rna": "AF478445.1"}, {"protein": "NP_001193907.1", "rna": "NM_001206978.2"}, {"protein": "NP_001193906.1", "rna": "NM_001206977.2"}]}, "alias": ["BAR", "FXR", "HRR-1", "HRR1", "PFIC5", "RIP14"], "ensembl": {"gene": "ENSG00000012504", "protein": ["ENSP00000188403", "ENSP00000315442", "ENSP00000376712", "ENSP00000446584", "ENSP00000446760", "ENSP00000446861", "ENSP00000447149", "ENSP00000448506", "ENSP00000448978", "ENSP00000496824", "ENSP00000496908"], "transcript": ["ENST00000188403", "ENST00000321046", "ENST00000392986", "ENST00000546380", "ENST00000548621", "ENST00000548884", "ENST00000549996", "ENST00000551184", "ENST00000551379", "ENST00000648861", "ENST00000649582"], "translation": [{"protein": "ENSP00000448506", "rna": "ENST00000548884"}, {"protein": "ENSP00000496824", "rna": "ENST00000649582"}, {"protein": "ENSP00000376712", "rna": "ENST00000392986"}, {"protein": "ENSP00000315442", "rna": "ENST00000321046"}, {"protein": "ENSP00000448978", "rna": "ENST00000549996"}, {"protein": "ENSP00000496908", "rna": "ENST00000648861"}, {"protein": "ENSP00000446760", "rna": "ENST00000546380"}, {"protein": "ENSP00000446584", "rna": "ENST00000548621"}, {"protein": "ENSP00000447149", "rna": "ENST00000551379"}, {"protein": "ENSP00000188403", "rna": "ENST00000188403"}, {"protein": "ENSP00000446861", "rna": "ENST00000551184"}], "type_of_gene": "protein_coding"}, "entrezgene": "9971", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 18.920811422, "exp_mis": 154.668584076, "exp_syn": 66.7977836297, "lof_z": 3.17018356968822, "mis_z": 1.28483072391326, "mu_lof": 1.36515682845e-06, "mu_mis": 1.36187259339e-05, "mu_syn": 5.70725660034e-06, "n_lof": 5.0, "n_mis": 122.0, "n_syn": 67.0, "p_li": 0.161696750786205, "p_null": 0.000646600555955824, "p_rec": 0.837656648657839, "syn_z": -0.0153388408539861}, "bp": 1461, "cds_end": 100957267, "cds_start": 100897165, "n_exons": 9, "nonpsych": {"exp_lof": 16.9449165018, "exp_mis": 139.80975381, "exp_syn": 60.278195982, "lof_z": 3.32696465828925, "mis_z": 1.44223310927567, "mu_lof": 1.36515682845e-06, "mu_mis": 1.36187259339e-05, "mu_syn": 5.70725660034e-06, "n_lof": 3.0, "n_mis": 106.0, "n_syn": 62.0, "p_li": 0.740683011245512, "p_null": 0.000124373340990164, "p_rec": 0.259192615413498, "syn_z": -0.139625923920315}, "nontcga": {"exp_lof": 17.3895782264, "exp_mis": 142.277538608, "exp_syn": 61.4363943048, "lof_z": 2.93084768765542, "mis_z": 1.30639411475921, "mu_lof": 1.36515682845e-06, "mu_mis": 1.36187259339e-05, "mu_syn": 5.70725660034e-06, "n_lof": 5.0, "n_mis": 111.0, "n_syn": 63.0, "p_li": 0.101701341895599, "p_null": 0.00148284189203241, "p_rec": 0.896815816212368, "syn_z": -0.126310052946654}, "transcript": "ENST00000551379.1"}, "exons": [{"cdsend": 100563489, "cdsstart": 100493323, "chr": "12", "position": [[100473865, 100474059], [100490815, 100490982], [100492502, 100492637], [100493269, 100493402], [100510777, 100511143], [100532457, 100532610], [100534889, 100535023], [100536511, 100536610], [100536947, 100537047], [100540671, 100540818], [100561884, 100561998], [100563250, 100564414]], "strand": 1, "transcript": "NM_001206977", "txend": 100564414, "txstart": 100473865}, {"cdsend": 100563489, "cdsstart": 100493323, "chr": "12", "position": [[100473865, 100474059], [100492502, 100492637], [100493269, 100493402], [100510777, 100511143], [100534889, 100535023], [100536511, 100536610], [100536947, 100537047], [100540671, 100540818], [100561884, 100561998], [100563250, 100564414]], "strand": 1, "transcript": "NM_001206978", "txend": 100564414, "txstart": 100473865}, {"cdsend": 100563489, "cdsstart": 100493323, "chr": "12", "position": [[100473865, 100474059], [100492502, 100492637], [100493269, 100493402], [100510777, 100511143], [100532457, 100532610], [100534889, 100535023], [100536511, 100536610], [100536947, 100537047], [100540671, 100540818], [100561884, 100561998], [100563250, 100564414]], "strand": 1, "transcript": "NM_001206979", "txend": 100564414, "txstart": 100473865}, {"cdsend": 100563489, "cdsstart": 100503387, "chr": "12", "position": [[100503359, 100503496], [100510777, 100511143], [100532457, 100532598], [100534889, 100535023], [100536511, 100536610], [100536947, 100537047], [100540671, 100540818], [100561884, 100561998], [100563250, 100564414]], "strand": 1, "transcript": "NM_001206992", "txend": 100564414, "txstart": 100503359}, {"cdsend": 100563489, "cdsstart": 100503387, "chr": "12", "position": [[100503359, 100503496], [100510777, 100511143], [100532457, 100532610], [100534889, 100535023], [100536511, 100536610], [100536947, 100537047], [100540671, 100540818], [100561884, 100561998], [100563250, 100564414]], "strand": 1, "transcript": "NM_001206993", "txend": 100564414, "txstart": 100503359}, {"cdsend": 100563489, "cdsstart": 100493323, "chr": "12", "position": [[100473865, 100474059], [100492502, 100492637], [100493269, 100493402], [100510777, 100511143], [100532457, 100532598], [100534889, 100535023], [100536511, 100536610], [100536947, 100537047], [100540671, 100540818], [100561884, 100561998], [100563250, 100564414]], "strand": 1, "transcript": "NM_005123", "txend": 100564414, "txstart": 100473865}, {"cdsend": 100564414, "cdsstart": 100564414, "chr": "12", "position": [[100473865, 100474059], [100492502, 100492637], [100493269, 100493402], [100510777, 100511143], [100532457, 100532598], [100534889, 100535023], [100536506, 100536610], [100536947, 100537047], [100540671, 100540818], [100561884, 100561998], [100563250, 100564414]], "strand": 1, "transcript": "NR_135146", "txend": 100564414, "txstart": 100473865}], "exons_hg19": [{"cdsend": 100957267, "cdsstart": 100887101, "chr": "12", "position": [[100867643, 100867837], [100884593, 100884760], [100886280, 100886415], [100887047, 100887180], [100904555, 100904921], [100926235, 100926388], [100928667, 100928801], [100930289, 100930388], [100930725, 100930825], [100934449, 100934596], [100955662, 100955776], [100957028, 100958192]], "strand": 1, "transcript": "NM_001206977", "txend": 100958192, "txstart": 100867643}, {"cdsend": 100957267, "cdsstart": 100887101, "chr": "12", "position": [[100867643, 100867837], [100886280, 100886415], [100887047, 100887180], [100904555, 100904921], [100928667, 100928801], [100930289, 100930388], [100930725, 100930825], [100934449, 100934596], [100955662, 100955776], [100957028, 100958192]], "strand": 1, "transcript": "NM_001206978", "txend": 100958192, "txstart": 100867643}, {"cdsend": 100957267, "cdsstart": 100887101, "chr": "12", "position": [[100867643, 100867837], [100886280, 100886415], [100887047, 100887180], [100904555, 100904921], [100926235, 100926388], [100928667, 100928801], [100930289, 100930388], [100930725, 100930825], [100934449, 100934596], [100955662, 100955776], [100957028, 100958192]], "strand": 1, "transcript": "NM_001206979", "txend": 100958192, "txstart": 100867643}, {"cdsend": 100957267, "cdsstart": 100897165, "chr": "12", "position": [[100897137, 100897274], [100904555, 100904921], [100926235, 100926376], [100928667, 100928801], [100930289, 100930388], [100930725, 100930825], [100934449, 100934596], [100955662, 100955776], [100957028, 100958192]], "strand": 1, "transcript": "NM_001206992", "txend": 100958192, "txstart": 100897137}, {"cdsend": 100957267, "cdsstart": 100897165, "chr": "12", "position": [[100897137, 100897274], [100904555, 100904921], [100926235, 100926388], [100928667, 100928801], [100930289, 100930388], [100930725, 100930825], [100934449, 100934596], [100955662, 100955776], [100957028, 100958192]], "strand": 1, "transcript": "NM_001206993", "txend": 100958192, "txstart": 100897137}, {"cdsend": 100957267, "cdsstart": 100887101, "chr": "12", "position": [[100867643, 100867837], [100886280, 100886415], [100887047, 100887180], [100904555, 100904921], [100926235, 100926376], [100928667, 100928801], [100930289, 100930388], [100930725, 100930825], [100934449, 100934596], [100955662, 100955776], [100957028, 100958192]], "strand": 1, "transcript": "NM_005123", "txend": 100958192, "txstart": 100867643}, {"cdsend": 100958192, "cdsstart": 100958192, "chr": "12", "position": [[100867643, 100867837], [100886280, 100886415], [100887047, 100887180], [100904555, 100904921], [100926235, 100926376], [100928667, 100928801], [100930284, 100930388], [100930725, 100930825], [100934449, 100934596], [100955662, 100955776], [100957028, 100958192]], "strand": 1, "transcript": "NR_135146", "txend": 100958192, "txstart": 100867643}], "generif": [{"pubmed": 12004058, "text": "Amino acids asparagine 354 and isoleucine 372 of Farnesoid X activated receptor are critical to its function"}, {"pubmed": 12554753, "text": "These results provide molecular evidence for a cross-talk between the FXR and PPARalpha pathways in humans."}, {"pubmed": 12660231, "text": "role in regulating syndecan-1 expression"}, {"pubmed": 12754200, "text": "FXR regulates bile acid amidation, a critical component of the enterohepatic circulation of bile acids"}, {"pubmed": 12761213, "text": "kininogen is a novel and direct target of farnesoid X receptor"}, {"pubmed": 12806625, "text": "Farnesoid X receptor (FXR) induces the UGT2B4 enzyme in hepatocytes; this study identifies UGT2B4 as a novel FXR target gene."}, {"pubmed": 12815072, "text": "demonstrated that FGF-19, acting as an FXR-induced signaling molecule, represses expression of the CYP7A1 gene; this signaling cascade defines a novel mechanism for feedback repression of bile acid biosynthesis"}, {"pubmed": 12891557, "text": "bile acid and synthetic activators of the nuclear FXR as negative regulators of Apo CIII expression."}, {"pubmed": 14527955, "text": "MDR3 expression is directly up-regulated by FXR in primary human hepatocytes"}, {"pubmed": 14684751, "text": "the existence of an auto-regulatory loop in FXR signaling pathways: the binding of each bile acid results in a different FXR conformations, which in turn differentially regulates expression of individual FXR targets"}, {"pubmed": 14988830, "text": "Loss of familial intrahepatic cholestasis-1 leads to diminished nuclear translocation of FXR, with subsequent potential for pathologic alterations in intestinal and hepatic bile acid transporter expression."}, {"pubmed": 14990788, "text": "FXR is expressed in a variety of normal and pathological human tissue"}, {"pubmed": 15187081, "text": "FXR is activated by DRIP205, which modulates the bile acid response of its target genes"}, {"pubmed": 15202934, "text": "PGC-1alpha mediates the ligand-dependent activation of FXR and transcription of SHP gene."}, {"pubmed": 15317749, "text": "Hepatic down-regulation of Farnesoid X receptor contributes to severety of familial intrahepatic cholestasis."}, {"pubmed": 15342685, "text": "FXR has a central role in lipid homeostasis"}, {"pubmed": 15454728, "text": "presence of two functional FXR recognition sites located in a 345-bp element within the 5'-flanking region of CYP3A4"}, {"pubmed": 15471871, "text": "studies provide evidence that farnesoid X-receptor(FXR) directly recruits specific chromatin modifying activity of co-activator-associated arginine methyltransferase 1 (CARM1) necessary for full potentiation of bile salt export pump (BSEP) locus in vivo"}, {"pubmed": 15564327, "text": "farnesoid X receptor regulates carbohydrate metabolism"}, {"pubmed": 15576845, "text": "the coordinate regulation of FXR target genes is lost in cerebrotendinous xanthomatosis"}, {"pubmed": 15590640, "text": "complement C3 expression is regulated by the bile acid receptor FXR"}, {"pubmed": 15604525, "text": "The FXR isoforms were recently identified that differ either at their N termini and/or by the presence of four amino acids in the hinge region."}, {"pubmed": 15721319, "text": "activation of FXR may suppress glycolysis and enhance oxidation of fatty acids via inactivation of the pyruvate dehydrogenase complex by increasing PDK4 expression"}, {"pubmed": 15817812, "text": "FXR-mediated activation of ICAM-1 could be further enhanced by TNF-alpha cotreatment in hepatocytes"}, {"pubmed": 16012168, "text": "Induction of alpha A crystallin expression in response to bile acid-activated FXR contributes to cellular defense against bile acid-induced hepatotoxicity"}, {"pubmed": 16037943, "text": "FXR agonists may increase gallbladder fluid secretion through transcriptional activation of VPAC1."}, {"pubmed": 16197915, "text": "These results show that the stimulation of ASCT2 expression in response to glutamine in part involves binding of FXR/RXR to the ASCT2 promoter."}, {"pubmed": 16251721, "text": "overexpression of human OSTalpha and OSTbeta facilitated the uptake of conjugated chenodeoxycholate and the activation of FXR target genes"}, {"pubmed": 16269519, "text": "OSTalpha/OSTbeta expression is induced by bile acids through ligand-dependent transactivation of both OST genes by the nuclear bile acid receptor/farnesoid X receptor (FXR)."}, {"pubmed": 16423920, "text": "These results indicate that expression of Ostalpha and Ostbeta are highly regulated in response to cholestasis and that this response is dependent on the FXR bile acid receptor."}, {"pubmed": 16460270, "text": "FXR is a potential therapeutic target for the treatment and prevention of numerous metabolic and lipid-related diseases"}, {"pubmed": 16494845, "text": "The results obtained using truncated PGC-1alpha proteins suggested that two regions are necessary for PGC-1alpha to interact with the DNA-binding complex of RXRalpha/FXR."}, {"pubmed": 16778009, "text": "Taken together, these results suggest that activation of FXR plays a critical role in regulating adipogenesis and insulin signaling."}, {"pubmed": 17047076, "text": "The farnesoid X receptor (FXR) was detected in normal and tumor breast tissue, with a high level of expression in ductal epithelial cells of normal breast and infiltrating ductal carcinoma cells."}, {"pubmed": 17054793, "text": "The bile acid receptor FXR is significantly overexpressed in Barrett's esophagus compared to normal mucosa, esophagitis and esophageal adenocarcinoma."}, {"pubmed": 17071613, "text": "an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration"}, {"pubmed": 17241392, "text": "The use of human liver slices in nuclear receptor metabolism research is reported; the farnesoid X receptor system was chosen as a model."}, {"pubmed": 17272748, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17333335, "text": "FXR is expressed in breast cancer interacts with ER"}, {"pubmed": 17495603, "text": "farnesoid X receptor exerts metabolic control beyond bile acid homeostasis, notably effects on HDL, triglyceride and glucose metabolism [review]"}, {"pubmed": 17507182, "text": "analysis of the 5'-flanking region of human FXR gene in HepG2 cells"}, {"pubmed": 17519356, "text": "Expression levels of FXR target genes are significantly reduced in livers harboring an FXR*1B allele."}, {"pubmed": 17681172, "text": "Functional variants of FXR may predispose to intrahepatic cholestasis of pregnancy."}, {"pubmed": 17681172, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17876519, "text": "summarize the current knowledge of the functions regulated by bile acids and how their physiological receptors,FXR, mediate the signaling underlying numerous cellular responses"}, {"pubmed": 17931734, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17931734, "text": "in three ethnically distinct populations there is a complex interaction of fxr alleles and other risk factors for the development of cholelithiasis"}, {"pubmed": 17988216, "text": "Expression of FXR in normal and cancer prostate epithelial cells and its activation by chenodeoxycholic acid."}, {"pubmed": 18029909, "text": "FXR is expressed and induces its target gene SHP in VSMCs, and activation of FXR and SHP lead to downregulation of important contributors to vascular inflammation and migration, notably COX-2 and iNOS."}, {"pubmed": 18436567, "text": "FXR has a role in modulating liver cell apoptosis"}, {"pubmed": 18514055, "text": "FXR appears to induce decorin expression at a transcriptional level."}, {"pubmed": 18563553, "text": "High farnesoid X receptor is associated with estrogen receptor-positive luminal-like breast cancer."}, {"pubmed": 18660489, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18668687, "text": "FIC1 signals to FXR via PKC zeta. FIC1-related liver disease is likely related to downstream effects of FXR on bile acid homeostasis."}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18755856, "text": "phosphorylation of FXR induced by PKCalpha directly modulates the ability of agonists to activate FXR"}, {"pubmed": 18768987, "text": "The data strongly suggest that FXRalpha is another member of the nuclear receptor superfamily implicated in the regulation of HBV core promoter activity and that bile acids could play an important role in the natural history of HBV infection."}, {"pubmed": 18769028, "text": "FXR is a new transcription factor of GLUT4, further elucidating the potential role for FXR in glucose metabolism."}, {"pubmed": 18779653, "text": "massively secreted biliary cholesterol from macrophages suppressed the expression of CYP7 proteins in a farnesoid X receptor (FXR)-dependent manner in HepG2 cells."}, {"pubmed": 18842595, "text": "p300 acts as a critical coactivator of FXR induction of SHP by acetylating histones at the promoter and FXR itself"}, {"pubmed": 18927204, "text": "the role of genetic variants in FXR itself, FXR target genes, and regulators of FXR in the pathophysiology of the liver and intestine has become increasingly evident--REVIEW"}, {"pubmed": 18972560, "text": "Potential role of FXR-mediated NF-kappaB inhibition for pathogenesis and treatment of liver diseases."}, {"pubmed": 19027009, "text": "ATP8B1 deficiency predisposes to cholestasis by favoring bile acid-induced injury in the canalicular membrane but does not directly affect FXR expression"}, {"pubmed": 19028791, "text": "Report antiatherosclerotic effect of farnesoid X receptor."}, {"pubmed": 19059462, "text": "In human adrenal cells, FXR increases transcription and expression of HSD3B2."}, {"pubmed": 19072826, "text": "HEX/Hex is a novel bile acid-induced FXR/Fxr target gene during adaptation of hepatocytes to chronic bile acid exposure."}, {"pubmed": 19105941, "text": "Expression of FXR is closely associated with lipid homeostasis in hepatocytes. Up-regulation of the expression of FXR may improve lipidosis in L02 cells."}, {"pubmed": 19150878, "text": "FXR promotes endothelial cell motility through coordinated regulation of FAK and MMP-9."}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19195631, "text": "FXR agonists and/or modulators may prove to be clinically useful for treating non-alcoholic fatty liver."}, {"pubmed": 19228886, "text": "Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064."}, {"pubmed": 19245866, "text": "Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors (farnesoid X receptor and vitamin D receptor) in the human biliary epithelium."}, {"pubmed": 19393742, "text": "these results suggest that IFNgamma induced STAT1 homodimers modulate the transcriptional repression of FXR gene in macrophages during inflammation-related cytokines."}, {"pubmed": 19418582, "text": "These results demonstrate that cystathionase is a farnesoid X receptor-regulated gene and provide a new molecular explanation for the pathophysiology of portal hypertension."}, {"pubmed": 19556342, "text": "ASCOM-MLL3 and ASCOM-MLL4 play redundant but essential roles in FXR transactivation via their histone 3 lysine 4 trimethylation activity."}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19833092, "text": "These results suggest that the Ku proteins function as corepressors for FXR."}, {"pubmed": 19864602, "text": "these findings provide evidence that FXR is an essential component of a network of nuclear receptors that regulate intestinal innate immunity and homeostasis."}, {"pubmed": 19910507, "text": "farnesoid X receptor loss significantly reduces fibrosis of the biliary type, but has no impact on non-cholestatic liver fibrosis"}, {"pubmed": 19913569, "text": "Studies provide new insights into the structure-activity relationships of bile acids and bile alcohols as FXR agonists."}, {"pubmed": 19948975, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and genetic testing. (HuGE Navigator)"}, {"pubmed": 19996107, "text": "analysis of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia"}, {"pubmed": 20026603, "text": "FXR is able to compete with steroidogenic factor 1 in binding to a common sequence present in the aromatase promoter region interfering negatively with its activity."}, {"pubmed": 20189675, "text": "Transcriptional regulation of the human bile acid and xenobiotic UGT1A3 by its substrate CDCA and FXR is shown"}, {"pubmed": 20346360, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20373033, "text": "These results demonstrated that fatty acid synthase and hepatic lipase might be FXR-regulated genes in liver cells."}, {"pubmed": 20399894, "text": "Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease."}, {"pubmed": 20447400, "text": "Data show that FXR is expressed and functional, as assessed by target gene expression analysis, in human islets and beta-cell lines."}, {"pubmed": 20827719, "text": "Direct role for FXR in OATP1B1 expression in liveer."}, {"pubmed": 20855565, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20883210, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21296199, "text": "FXR activation in obstructive cholestasis might worsen liver injury by hijacking a protective mechanism regulated by CAR and provides a new molecular explanation to the pathophysiology of cholestasis."}, {"pubmed": 21323950, "text": "FXR positivity was useful to distinguish dysplasia and adenocarcinoma in patietns with Barrett's esophagus"}, {"pubmed": 21364590, "text": "FXR overexpression plays an important role in lymphatic metastasis of pancreatic cancer and downregulation of FXR is an effective approach for inhibition of pancreatic tumour progression."}, {"pubmed": 21431940, "text": "FXR was down-regulated at both mRNA and protein levels in the liver specimens of systemic lupus erythematosus patients with liver injury."}, {"pubmed": 21596433, "text": "this study has shown very low levels of expression of FXR and its hepatic target genes BSEP and SHP in normal and cholestatic placentas"}, {"pubmed": 21619550, "text": "These results suggest that FXR increases the resistance of human and murine gastric epithelial cells to inflammation-mediated damage."}, {"pubmed": 21633855, "text": "Heterozygous termination codon mutation of NR1H4 R176X was found in idiopathic infantile cholestasis. This novel mutation is useful to establish differential diagnosis of and prognosis for idiopathic infantile cholestasis."}, {"pubmed": 21856289, "text": "DAX1 acts as a co-repressor to negatively modulate FXR transactivity."}, {"pubmed": 21862343, "text": "[review] The effects of FXR activation are not exclusive to the tissue where it is present, because receptor crosstalk affects tissues throughout the body."}, {"pubmed": 21887309, "text": "FXR activation in the ileum is decreased in patients with Crohn's colitis."}, {"pubmed": 21893226, "text": "These data support a new role for FXR in the modulation of osteoblast/adipocyte balance."}, {"pubmed": 21988803, "text": "The imbalance of ratio of free and conjugated bile acids may play an important role in tumorigenesis of cholangiocarcinoma. FXR may mediate the effects induced by the bile acids."}, {"pubmed": 22146319, "text": "In conclusion, our study identified microRNA-421 functions as an oncomiR in BTC by targeting FXR."}, {"pubmed": 22223860, "text": "Ileal bile acid binding protein is necessary for the full activation of farnesoid X receptor alpha by bile acids."}, {"pubmed": 22252013, "text": "Data indicate gorgosterol as a farnesoid X-activated receptor (FXR) antagonist."}, {"pubmed": 22265968, "text": "In hepatocytes, FXR represses production of miR-199a-3p"}, {"pubmed": 22266736, "text": "Data indicate the steroids 1 and 2 showed notable inhibitory activity against farnesoid X-activated receptor (FXR)."}, {"pubmed": 22285937, "text": "Results provide a way to development of a dual PXR agonist/FXR antagonist with a robust immunomodulatory activity and endowed with the ability to modulate the expression of bile acid-regulated genes in the liver."}, {"pubmed": 22446874, "text": "Results suggest that miR-421 may serve as a novel molecular target for manipulating FXR expression in hepatocyte."}, {"pubmed": 22474109, "text": "Several lines of evidence suggest that down-regulation of FXR has a role in hepatocarcinogenesis; data from tissue bank samples suggest that FXR expression is down-regulated in hepatocellular carcinoma compared with normal liver tissue."}, {"pubmed": 22550135, "text": "the mechanisms of metabolic regulation by FXR and TGR5"}, {"pubmed": 22558273, "text": "The binding of STAT-1 to specific responsive elements in the promoter of PPARgamma and FXR and MCP-1 shifts macrophages toward a pro-atherogenetic phenotype."}, {"pubmed": 22561792, "text": "These results suggest that FGF19 is transcriptionally activated through multiple Farnesoid X receptor-responsive elements in the promoter region"}, {"pubmed": 22609541, "text": "FXR is highly expressed in the liver and gut, relative to other tissues, and contributes to the maintenance of cholesterol/bile acid homeostasis by regulating a variety of metabolic enzymes and transporters. [Review]"}, {"pubmed": 22817871, "text": "data suggest FXR-mediated upregulation of cytokine inducible SH2-containing protein (CISH) may play an important role in the homeostasis of cytokine signal networks and be beneficial to control cytokine-associated inflammatory diseases"}, {"pubmed": 22898327, "text": "Although the enhanced expression of FXR may be involved in the stimulation of chemoresistance that occurs during treatment, FXR up-regulation is not required for the presence of the multidrug resistance phenotype of colorectal adenocarcinoma"}, {"pubmed": 22929053, "text": "Data show that farnesoid X receptor NR1H4 is associated with bowel diseases (IBD)."}, {"pubmed": 22952826, "text": "a novel role of FXR in regulating the expression of p62"}, {"pubmed": 22969091, "text": "FXR stimulates cell proliferation by suppressing p16/INK4a expression."}, {"pubmed": 23042943, "text": "in human hepatocellular carcinoma, FXR expression was significantly reduced and was positively correlated with multiple malignant clinicopathological characteristics."}, {"pubmed": 23056173, "text": "Data indicate that N-myc downstream-regulated gene 2 (NDRG2) is a novel direct target gene of farnesoid X receptor (FXR) in mouse liver and human hepatoma cell lines"}, {"pubmed": 23119029, "text": "in human colon cancer cells Src-mediated cross-talk between FXR and EGFR modulates ERK phosphorylation, thereby regulating intestinal cell proliferation and tumorigenesis."}, {"pubmed": 23251605, "text": "The basal expression of ATP8B1 is driven by a housekeeping-like promoter located 71 kb upstream of the first protein coding exon, and is independent of bile acids and farnesoid X receptor."}, {"pubmed": 23348121, "text": "FXR expression is inversely correlated with neoplastic progression and severity of inflammation in ulcerative colitis (UC). Patients with primary sclerosing cholangitis-UC have diminished FXR expression in the proximal colon compared to UC patients."}, {"pubmed": 23462506, "text": "K210R slightly but significantly decreased farnesoid X receptor/retinoid X receptor (RXR) binding affinity."}, {"pubmed": 23507574, "text": "Chemerin, a novel target gene of FXR, is related to nonalcoholic steatohepatitis."}, {"pubmed": 23519696, "text": "Identify a novel pathway involving FXR, miR-144, and ABCA1 that together regulate plasma HDL-cholesterol."}, {"pubmed": 23530060, "text": "FXR transrepresses the expression of genes involved in glycolysis in human hepatocytes."}, {"pubmed": 23546875, "text": "FXR is subject to SUMOylation that regulates its capacity to transactivate its target genes in normal liver and during obstructive cholestasis."}, {"pubmed": 23620138, "text": "By increasing CETP expression, FXR activation leads to a proatherogenic lipoprotein profile"}, {"pubmed": 23640969, "text": "genetic association study in healthy population in Germany: Data suggest that SNP rs4764980 in NR1H4 is associated with fasting glycemia and fasting/post-glucose-load free fatty acids (FFA); SNP rs11110390 is associated with fasting/postload FFA."}, {"pubmed": 23767959, "text": "Data suggest that diacylglycerol kinase theta is a key mediator of bile-acid-stimulated modulation of farnesoid X receptor/mTOR complex 2/Akt signaling pathway and glucose metabolism/homoeostasis in hepatocytes."}, {"pubmed": 23784309, "text": "Studies suggest important functions for the nuclear receptor farnesoid X receptor (FXRalpha) in steroid metabolism."}, {"pubmed": 23861371, "text": "Data suggest that FXR/NR1H4 in mouse hepatocytes but not in human or rat hepatocytes regulates inflammatory processes through ORM/AGP transcriptional control of ORM/AGP (orosomucoid/alpha1-acid glycoprotein) gene cluster."}, {"pubmed": 23916961, "text": "Data reveal a novel antisecretory role for the FXR in colonic epithelial cells."}, {"pubmed": 23928191, "text": "kidney, intestines and liver distribution of the farnesoid X receptor isoforms depends on the bile acid pool composition"}, {"pubmed": 24002920, "text": "FXR regulates BSEP in an isoform-dependent and species-specific manner"}, {"pubmed": 24037988, "text": "show that FXR interacts with and is O-GlcNAcylated by O-GlcNAc transferase in its N-terminal AF1 domain"}, {"pubmed": 24043304, "text": "These results identified poly(ADP-ribosyl)ation of farnesoid X receptor by PARP1 as a key step in oxidative-stress-induced hepatic cell death."}, {"pubmed": 24169962, "text": "NR1H4 methylation is associated with colon cancer."}, {"pubmed": 24211198, "text": "this study has identified apoF as likely another target gene of FXR."}, {"pubmed": 24297698, "text": "Using cell lines differentially expressing FXRalpha in overexpression and silencing experiments, we demonstrated that SIRT1 activated the core promoter in an FXRalpha- and PGC-1alpha-dependent manner"}, {"pubmed": 24321096, "text": "These results suggest that SREBP-2 negatively regulates the FXR-mediated transcriptional activation of the FGF19 gene in human intestinal cells."}, {"pubmed": 24498169, "text": "significant differences at the distal (-1890) and proximal promoter (-358) CpG sites of the FXR/NR1H4 and at the distal PXR/NR1I2 (-1224) promoter, which were consistently less methylated in ICP cases when compared with controls."}, {"pubmed": 24531544, "text": "AMP-Kinase directly phosphorylates and regulates FXR transcriptional activity to precipitate liver injury under conditions favoring cholestasis."}, {"pubmed": 25043081, "text": "Compared with normal gallbladder tissues, FXR expression was decreased and MCL1 expression was increased in GBC, during progression of tumor node metastasis (TNM) stage"}, {"pubmed": 25086996, "text": "NHR1H4 genotype increases the risk for spontaneous bacterial peritonitis in live cirrhosis patients."}, {"pubmed": 25138215, "text": "Intestinal nuclear bile acid farnesoid X receptor is regulated transcriptionally by CDX2."}, {"pubmed": 25198545, "text": "established genome-wide human FXR binding and transcriptome profiles. These results will aid in determining the human FXR functions, as well as judging to what level the mouse models could be used to study human FXR functions"}, {"pubmed": 25242139, "text": "Three FXR gene variants (rs35724, rs11110385, rs11110386) were identified as potential susceptibility factors for cholelithiasis in a German cohort in gender- and weight-dependent manners"}, {"pubmed": 25257666, "text": "These results provide important information to prioritize chemicals for further investigation, and suggest possible modes of action of compounds in FXR signaling."}, {"pubmed": 25363753, "text": "Results show that HRG is a novel transcriptional target gene of FXR in human hepatoma cells, human upcyteVR primary hepatocytes and 3D human liver microtissues in vitro and in mouse liver in vivo."}, {"pubmed": 25400456, "text": "FXR agonist, GW4064, upregulates adipokine expression in preadipocytes and HepG2 cells."}, {"pubmed": 25496033, "text": "FXR may regulate SOD3 expression to suppress reactive oxygen species production, resulting in decreasing JNK activity."}, {"pubmed": 25596928, "text": "our data showed that bile acid-activated FXR stimulates miR-22-silenced CCNA2, a novel pathway for FXR to exert its protective effect in the gastrointestinal tract."}, {"pubmed": 25655198, "text": "AB23A produces protective effect against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes."}, {"pubmed": 26019035, "text": "Liver nuclear receptors, FXR and SHP, and bile acid transporters, NTCP and BSEP, are associated with the progression of NAFLD."}, {"pubmed": 26134028, "text": "FXR activation in L cells decreases proglucagon expression by interfering with the glucose-responsive factor Carbohydrate-Responsive Element Binding Protein (ChREBP) and GLP-1 secretion by inhibiting glycolysis."}, {"pubmed": 26241054, "text": "these data demonstrate that copper-mediated nuclear receptor dysfunction disrupts liver function in WD and potentially in other disorders associated with increased hepatic copper levels."}, {"pubmed": 26292095, "text": "IL-18 repressed FXR mRNA and protein levels in HepG2 cells."}, {"pubmed": 26302777, "text": "miR-122 is a novel target gene of FXR, and the upregulation of miR-122 by FXR represses the growth of hepatocellular carcinoma cells, suggesting that FXR may serve as a key transcriptional regulator for manipulating miR-122 expression"}, {"pubmed": 26305715, "text": "we drew a conclusion that curcumin attenuated Alcoholic liver disease by modulating lipid deposition in hepatocytes via a Nrf2/FXR activation-dependent mechanism"}, {"pubmed": 26416445, "text": "induction of SOCS3 may be a novel mechanism by which FXR exerts its anti-hepatocellular carcinoma effects"}, {"pubmed": 26488943, "text": "FXR is decreased in obese animal models associated with INS resistance. Regulation of bile acids and FXR in the stage of obesity may prevent more metabolism disorders."}, {"pubmed": 26607331, "text": "this is the first report of bile acid derivatives able to antagonize GPBAR1 and and farnesoid X receptor (FXR) modulatory activity."}, {"pubmed": 26670557, "text": "FXR signalling in ileum biopsies of humans positively correlates with body mass index."}, {"pubmed": 26728993, "text": "FXR may promote the proliferation of tumor cells and the hepatocytes in the process of liver regeneration by activating the PDK4-mediated metabolic reprogramming to generate glycolytic intermediates essential for rapid biomass generation, establishing a mechanistic link between cell proliferation and metabolic switch."}, {"pubmed": 26888176, "text": "Mutations in NR1H4 cause progressive familial intrahepatic cholestasis."}, {"pubmed": 26899873, "text": "Activated FXR inhibits leptin signaling and counteracts tumor-promoting activities of cancer-associated fibroblasts in breast malignancy."}, {"pubmed": 27045028, "text": "In diabetic humans, there is decreased FXR expression in the kidney.  FXR plays an important role in Diabetic Kidney Disease."}, {"pubmed": 27109477, "text": "Taken together, our data provide the first evidence that FXR suppresses proliferation of human liver cancer cells via the inhibition of the mTOR/S6K signaling pathway. FXR expression can be used as a biomarker of personalized mTOR inhibitor treatment assessment for liver cancer patients."}, {"pubmed": 27138288, "text": "The results indicated that epigenetically regulated miR-449a targets CREB5 to increase FXRalpha expression, thereby promoting HBV replication and gene expression. Our findings provide a new understanding of the role of miRNAs in HBV replication"}, {"pubmed": 27251172, "text": "These studies investigated in differentiated HepaRG cells and in primary human hepatocytes (PHHs) effects of FXR activation on HBV replication and of infection on the FXR pathway."}, {"pubmed": 27471003, "text": "FXR regulates serum triglyceride level in part through PLA2G12B."}, {"pubmed": 27596062, "text": "We combined hydrogen deuterium exchange mass spectrometry with computational studies for dissecting molecular recognition and conformational impact of prenylflavonoid interactions on the ligand binding domain of FXR."}, {"pubmed": 27738335, "text": "the presented evidence suggested that WA can inhibit HCC cell proliferationand tumorigenesis through miR-22-repressed CCNA2, which was at least partially through FXR regulation"}, {"pubmed": 27758768, "text": "FXR ligands to inhibit platelet activation."}, {"pubmed": 27846919, "text": "Data suggest that TGR5 and FXR in intestinal mucosa are important for glucose homeostasis, in particular in metabolic disorders such as type 2 diabetes and obesity. (TGR5 = membrane-type receptor for bile acids TGR5; FXR = farnesoid X receptor) [REVIEW; Congress as Topic]"}, {"pubmed": 27853248, "text": "These results suggested that FXR may serve as an important negative regulator for manipulating Smad3 expression, and the FXR/Smad3 pathway may be a novel target for the treatment of renal fibros"}, {"pubmed": 28201649, "text": "Lys-325 is a non-canonical site of SUMOylation of human FXR.CK2 is the priming effector that phosphorylates Ser-327, resulting in enhanced SUMO2 conjugation, which then directs the ubiquitination and degradation of FXR through the recruitment of the SUMO-dependent ubiquitin E3 ligase RNF4."}, {"pubmed": 28287408, "text": "PPARalpha and FXR function coordinately to integrate liver energy balance."}, {"pubmed": 28400119, "text": "Loss of FXR or its down-regulation is associated with higher bile acids concentrations and with a pro-tumorigenic phenotype. (Review)"}, {"pubmed": 28402278, "text": "we proposed a model to link FXR to Sp1, which included triggered FXR, p38/MAPK and/or PI3K/AKT signaling and phosphorylated Sp1, to illustrate the potential crosstalk between the two factors."}, {"pubmed": 28485172, "text": "FXR may be implicated at the earlier stage of breast malignant disease progression, being a strong and independent prognosticator of favorable overall and disease-free survival in invasive breast carcinoma."}, {"pubmed": 28496032, "text": "It regulates the growth of renal adenocarcinoma cells."}, {"pubmed": 28535186, "text": "we conclude that FXR-Gank-TSPs-Stem cells pathway is a key determinant of liver cancer in animal models and in pediatric liver cancer. Our data provide a strong basis for development of FXR-Gank-based therapy for treatment of patients with hepatoblastoma"}, {"pubmed": 28619996, "text": "Treatment with LXR and FXR ligands initiates coated platelet formation, which is thought to support coagulation but results in desensitization to platelet stimuli through inhibition of alphaIIbbeta3 consistent with their ability to inhibit platelet function and stable thrombus formation in vivo."}, {"pubmed": 28746779, "text": "FXR protein levels vary markedly between normal liver, NAFLD without NASH, and NASH. Low levels of FXR are independently associated with NASH."}, {"pubmed": 28762281, "text": "This study provides some data suggesting the possible involvement of FXR in the pathophysiology and development of thyroid neoplasms. In particular, we found that there are differences regarding FXR expression between papillary carcinomas and hyperplastic nodules, being also correlated with some patients' clinicopathological parameters."}, {"pubmed": 28916388, "text": "Activation of FXR inhibits, whereas TGR5 activation may promote, cholangiocarcinoma progression by regulating proliferation, migration and mitochondrial energy metabolism."}, {"pubmed": 28970500, "text": "FXR up-regulation suppresses hepatocellular carcinoma cells proliferation and migration."}, {"pubmed": 29377207, "text": "FXR pathway activation increases XBP1 splicing and enhances p-IRE1alpha expression in liver"}, {"pubmed": 29771182, "text": "These findings indicate a previously unknown role for PPARA and NR1H4 in regulating the autophagy-ciliogenesis axis."}, {"pubmed": 29921626, "text": "study demonstrated for the first time a novel target for farnesoid X-activated receptor (FXR) and that the activated receptor alters the acquisition of sperm fertilising ability"}, {"pubmed": 29929982, "text": "Decreased expression of FXR is associated with obstructive cholestasis."}, {"pubmed": 29958417, "text": "FXR agonist treatment enhanced TGF-beta-induced epithelial mesenchymal transition(EMT) morphologic changes and FXR antagonist inhibited the effect of TGF-beta;. Thus, FXR activation enhances EMT in hepatocellular carcinoma (HCC) and FXR antagonists may be EMT-suppressing drug candidates."}, {"pubmed": 29968724, "text": "Study shows that FXR is phosphorylated at Y67 by non-receptor tyrosine kinase, Src, in response to postprandial FGF19 which is critical for its nuclear localization and transcriptional regulation of bile acids levels and identifies Src-mediated FXR phosphorylation as a potential therapeutic target and biomarker for bile acids-related enterohepatic diseases."}, {"pubmed": 30013008, "text": "Studies indicate that the deregulation of farnesoid X receptor (FXR) may lead to abnormalities of specific organs and metabolic dysfunction [Review]."}, {"pubmed": 30106441, "text": "Low FXR expression is associated with colorectal cancer."}, {"pubmed": 30176263, "text": "Data show that nuclear Farnesoid X Receptor (FXR) is expressed in cancer-associated Fibroblasts (CAFs), CAFs isolated from patients and treatment with the selective FXR agonist GW4064 decreased CAF migration."}, {"pubmed": 30206765, "text": "Our findings point to concurrent PPARalpha and FXR activation, triggered by RYGB, as a potential mechanism to improve NASH."}, {"pubmed": 30275017, "text": "FXR and RXR bind to the transcriptional coregulator steroid receptor coactivator 1 with higher affinity when they are part of the heterodimer complex than when they are in their respective monomeric states."}, {"pubmed": 30354208, "text": "FXR activation increases LDLR expression in liver tissue by a post-transcriptional regulatory mechanism involving LDLR mRNA-stabilizing factor HuR."}, {"pubmed": 30366773, "text": "Disease-causing mutations, including ATP8B1, ABCB11, ABCB4, ABCC2, TJP2, NR1H4 (FXR), JAG1, AKR1D1, CYP7B1, PKHD1, ATP7B, and SLC25A13, were identified. Nine patients had unpredicted genetic diagnosis with atypical phenotype or novel mutations in the investigational genes."}, {"pubmed": 30844798, "text": "FXR mRNA expression at the terminal ileum was increased in irritable bowel syndrome (IBS) patients. Chenodeoxycholic acid (CDCA) significantly decreased trans-epithelial electrical resistance (TEER), increased permeability, and increased IL-8 release from Caco-2 cells. Pre-incubation with FXR antagonist guggulsterone blocked CDCA-mediated IL-8 release; however, the decrease in TEER was not reversed."}, {"pubmed": 30884797, "text": "The newly synthesized analogues were evaluated on human orthologs of FXR and GPBAR1 receptors in a luciferase reporter assay. As shown, the introduction of a nonacidic side chain on the 6-ethylchenodeoxycholic scaffold produced beneficial effects on FXR with compounds 1, 2, and 3 emerging as high efficacious FXR agonists in transactivation assays, with the above efficacy data translating also in good EC50 value"}, {"pubmed": 30967475, "text": "FXR suppresses MMP7 transcription by binding to a negative FXR-responsive element in the 5' MMP7 promoter, an event that inhibited colon cancer cell proliferation and invasion."}, {"pubmed": 31062417, "text": "The farnesoid X receptor SNP rs35724 was associated with a reduced risk for development of ascites and liver-related mortality in patients with advanced chronic liver disease."}, {"pubmed": 31105019, "text": "Progressive familial intrahepatic cholestasis 4 and Progressive familial intrahepatic cholestasis 5 involve tight junction protein-2 gene and NR1H4 gene encoding for farnesoid X receptor.[review]"}, {"pubmed": 31266946, "text": "Synthetic partial agonist of FXR is conferred by a kink in helix alpha11 that destabilizes the alpha11-alpha12 loop, a critical determinant for helix alpha12 orientation."}, {"pubmed": 31623375, "text": "Study found an increased expression of Farnesoid X receptor (FXR) in villus cells during obesity and likely mediated the increase in ASBT expression level."}, {"pubmed": 31779647, "text": "study found a positive correlation between farnesoid X receptor (FXR) expression and miR-23b-3p level in osteosarcoma cells (OS); upregulated FXR by GW4064 can suppress OS cell development, and the suppressive effects may rely on miR-23b-3p/CCNG1 pathway"}, {"pubmed": 31949131, "text": "The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines."}, {"pubmed": 32001246, "text": "NGF modulates autophagy flux via FXR upregulation and protects hepatocytes against bile acid-induced cytotoxicity"}, {"pubmed": 32001325, "text": "FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis."}, {"pubmed": 32299194, "text": "The Role of Nuclear Receptor Subfamily 1 Group H Member 4 (NR1H4) in Colon Cancer Cell Survival through the Regulation of c-Myc Stability."}, {"pubmed": 32581266, "text": "Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5p."}, {"pubmed": 32597704, "text": "Reabsorption of bile acids regulated by FXR-OATP1A2 is the main factor for the formation of cholesterol gallstone."}, {"pubmed": 32650752, "text": "Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells."}, {"pubmed": 32678214, "text": "Genetic variation in the farnesoid X-receptor predicts Crohn's disease severity in female patients."}, {"pubmed": 32712104, "text": "FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs."}, {"pubmed": 32807788, "text": "Farnesoid X receptor antagonizes Wnt/beta-catenin signaling in colorectal tumorigenesis."}, {"pubmed": 32846898, "text": "Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells."}, {"pubmed": 33029898, "text": "A novel role for farnesoid X receptor in the bile acid-mediated intestinal glucose homeostasis."}, {"pubmed": 33568795, "text": "The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer."}, {"pubmed": 33686512, "text": "Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor."}, {"pubmed": 33938457, "text": "Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis."}, {"pubmed": 33968024, "text": "Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages."}, {"pubmed": 34090620, "text": "Differential roles of farnesoid X receptor (FXR) in modulating apoptosis in cancer cells."}, {"pubmed": 34145381, "text": "Bile acid-induced tissue factor activity in hepatocytes correlates with activation of farnesoid X receptor."}, {"pubmed": 34268860, "text": "NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease."}, {"pubmed": 34270928, "text": "FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption."}, {"pubmed": 34289507, "text": "Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities."}, {"pubmed": 34510400, "text": "Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach."}, {"pubmed": 34995680, "text": "Pleiotropic roles of FXR in liver and colorectal cancers."}, {"pubmed": 35091108, "text": "Structural insight into the molecular mechanism of cilofexor binding to the farnesoid X receptor."}, {"pubmed": 35251469, "text": "Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4."}, {"pubmed": 35347542, "text": "Farnesoid X receptor functions in cervical cancer via the p14(ARF)-mouse double minute 2-p53 pathway."}, {"pubmed": 35436901, "text": "Identification of two novel pathogenic variants of the NR1H4 gene in intrahepatic cholestasis of pregnancy patients."}, {"pubmed": 35563650, "text": "Enhancement of Farnesoid X Receptor Inhibits Migration, Adhesion and Angiogenesis through Proteasome Degradation and VEGF Reduction in Bladder Cancers."}, {"pubmed": 35767918, "text": "Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes."}, {"pubmed": 35988420, "text": "A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARalpha) and farnesoid X receptor (FXR)."}, {"pubmed": 36090996, "text": "Reduced peroxisome proliferator-activated receptor-alpha and bile acid nuclear receptor NR1H4/FXR may affect the hepatic immune microenvironment of biliary atresia."}, {"pubmed": 36129029, "text": "CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis."}, {"pubmed": 36340269, "text": "Transcription Factor FXR Activates DHRS9 to Inhibit the Cell Oxidative Phosphorylation and Suppress Colon Cancer Progression."}, {"pubmed": 36430444, "text": "The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity."}, {"pubmed": 36737665, "text": "The role of the farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases."}, {"pubmed": 36805269, "text": "Differential Expression of FXR and Genes Involved in Inflammation and lipid Metabolism Indicate Adipose Tissue Dysfunction in Gestational Diabetes."}, {"pubmed": 36939994, "text": "NR1H4-mediated circRHOBTB3 modulates the proliferation, metastasis, and Warburg effects of cervical cancer through interacting with IGF2BP3."}, {"pubmed": 37337149, "text": "Regulon analysis identifies protective FXR and CREB5 in proximal tubules in early diabetic kidney disease."}, {"pubmed": 37487659, "text": "Farnesoid X receptor represses human sulfotransferase 1A3 expression through direct binding to the promoter."}, {"pubmed": 37697930, "text": "Farnesoid X receptor enhances epithelial ACE2 expression and inhibits virally induced IL-6 secretion: implications for intestinal symptoms of SARS-CoV-2."}, {"pubmed": 37823198, "text": "Farnesoid X receptor prevents neutrophil extracellular traps via reduced sphingosine-1-phosphate in chronic kidney disease."}, {"pubmed": 37903763, "text": "Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis."}, {"pubmed": 37918680, "text": "Farnesoid X receptor overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in nonalcoholic fatty liver disease."}, {"pubmed": 38183609, "text": "FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease."}, {"pubmed": 38493698, "text": "Elevated expression of LCN13 through FXR activation ameliorates hepatocellular lipid accumulation and inflammation."}, {"pubmed": 38641832, "text": "NR1H4 disease: rapidly progressing neonatal intrahepatic cholestasis and early death."}], "genomic_pos": {"chr": "12", "end": 100564414, "ensemblgene": "ENSG00000012504", "start": 100473708, "strand": 1}, "genomic_pos_hg19": {"chr": "12", "end": 100958191, "start": 100867486, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0000122", "qualifier": "involved_in", "term": "negative regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0000122", "pubmed": 21757002, "qualifier": "involved_in", "term": "negative regulation of transcription by RNA polymerase II"}, {"evidence": "IC", "gocategory": "BP", "id": "GO:0001080", "pubmed": 21757002, "qualifier": "involved_in", "term": "nitrogen catabolite activation of transcription from RNA polymerase II promoter"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001678", "qualifier": "involved_in", "term": "intracellular glucose homeostasis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006357", "pubmed": 10334992, "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006366", "qualifier": "involved_in", "term": "transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006954", "qualifier": "involved_in", "term": "inflammatory response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007043", "qualifier": "involved_in", "term": "cell-cell junction assembly"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007219", "qualifier": "involved_in", "term": "Notch signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008206", "qualifier": "involved_in", "term": "bile acid metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010804", "qualifier": "involved_in", "term": "negative regulation of tumor necrosis factor-mediated signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010903", "pubmed": 27471003, "qualifier": "acts_upstream_of_or_within", "term": "negative regulation of very-low-density lipoprotein particle remodeling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010988", "pubmed": 12660231, "qualifier": "involved_in", "term": "regulation of low-density lipoprotein particle clearance"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030154", "qualifier": "involved_in", "term": "cell differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030522", "qualifier": "involved_in", "term": "intracellular receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032689", "pubmed": 21242261, "qualifier": "involved_in", "term": "negative regulation of type II interferon production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032692", "qualifier": "involved_in", "term": "negative regulation of interleukin-1 production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032703", "qualifier": "involved_in", "term": "negative regulation of interleukin-2 production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032715", "qualifier": "involved_in", "term": "negative regulation of interleukin-6 production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032720", "pubmed": 21242261, "qualifier": "involved_in", "term": "negative regulation of tumor necrosis factor production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032740", "pubmed": 21242261, "qualifier": "involved_in", "term": "positive regulation of interleukin-17 production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0034162", "qualifier": "involved_in", "term": "toll-like receptor 9 signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0034255", "pubmed": 21757002, "qualifier": "involved_in", "term": "regulation of urea metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035356", "pubmed": 20447400, "qualifier": "involved_in", "term": "intracellular triglyceride homeostasis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035774", "qualifier": "involved_in", "term": "positive regulation of insulin secretion involved in cellular response to glucose stimulus"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0038183", "qualifier": "involved_in", "term": "bile acid signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0038183", "qualifier": "involved_in", "term": "bile acid signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0038183", "pubmed": 23767959, "qualifier": "involved_in", "term": "bile acid signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0038185", "pubmed": 10334992, "qualifier": "involved_in", "term": "nuclear receptor-mediated bile acid signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042632", "qualifier": "involved_in", "term": "cholesterol homeostasis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042742", "qualifier": "involved_in", "term": "defense response to bacterium"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043066", "pubmed": 20447400, "qualifier": "involved_in", "term": "negative regulation of apoptotic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043124", "pubmed": 21242261, "qualifier": "involved_in", "term": "negative regulation of canonical NF-kappaB signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045087", "qualifier": "involved_in", "term": "innate immune response"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045893", "pubmed": 27471003, "qualifier": "acts_upstream_of_or_within", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 23767959, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045944", "pubmed": 21757002, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0046628", "qualifier": "involved_in", "term": "positive regulation of insulin receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0050728", "qualifier": "involved_in", "term": "negative regulation of inflammatory response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0055089", "qualifier": "involved_in", "term": "fatty acid homeostasis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0061178", "pubmed": 20447400, "qualifier": "involved_in", "term": "regulation of insulin secretion involved in cellular response to glucose stimulus"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0070857", "pubmed": 21757002, "qualifier": "involved_in", "term": "regulation of bile acid biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071222", "qualifier": "involved_in", "term": "cellular response to lipopolysaccharide"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071398", "pubmed": 20447400, "qualifier": "involved_in", "term": "cellular response to fatty acid"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0071417", "pubmed": 21757002, "qualifier": "involved_in", "term": "cellular response to organonitrogen compound"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071638", "qualifier": "involved_in", "term": "negative regulation of monocyte chemotactic protein-1 production"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0090181", "pubmed": 21757002, "qualifier": "involved_in", "term": "regulation of cholesterol metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1903413", "pubmed": 10334992, "qualifier": "involved_in", "term": "cellular response to bile acid"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1904179", "qualifier": "involved_in", "term": "positive regulation of adipose tissue development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1905695", "pubmed": 23767959, "qualifier": "involved_in", "term": "positive regulation of phosphatidic acid biosynthetic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:2000213", "pubmed": 21757002, "qualifier": "involved_in", "term": "positive regulation of glutamate metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:2001250", "qualifier": "involved_in", "term": "positive regulation of ammonia assimilation cycle"}], "CC": [{"evidence": "IC", "gocategory": "CC", "id": "GO:0000785", "pubmed": 27471003, "qualifier": "part_of", "term": "chromatin"}, {"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0000791", "pubmed": 21757002, "qualifier": "part_of", "term": "euchromatin"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043235", "pubmed": 10334992, "qualifier": "part_of", "term": "receptor complex"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0090575", "qualifier": "part_of", "term": "RNA polymerase II transcription regulator complex"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0000977", "pubmed": 23767959, "qualifier": "enables", "term": "RNA polymerase II transcription regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000978", "pubmed": 21757002, "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000981", "pubmed": 21757002, "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IPI", "id": "GO:0001221", "pubmed": 14701856, "qualifier": "enables", "term": "transcription coregulator binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001228", "pubmed": [21757002, 24211198, 27471003], "qualifier": "enables", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003700", "pubmed": 9223286, "qualifier": "enables", "term": "DNA-binding transcription factor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004879", "qualifier": "enables", "term": "nuclear receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004879", "pubmed": [23767959, 27471003], "qualifier": "enables", "term": "nuclear receptor activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0004879", "pubmed": 21757002, "qualifier": "enables", "term": "nuclear receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [12917342, 14684751, 15317749, 21532585, 22345554], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0008270", "qualifier": "enables", "term": "zinc ion binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0016922", "pubmed": 21757002, "qualifier": "enables", "term": "nuclear receptor binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0032052", "qualifier": "enables", "term": "bile acid binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0032052", "pubmed": 21757002, "qualifier": "enables", "term": "bile acid binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0032052", "pubmed": 21757002, "qualifier": "enables", "term": "bile acid binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0043565", "pubmed": 12815072, "qualifier": "enables", "term": "sequence-specific DNA binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046965", "qualifier": "enables", "term": "nuclear retinoid X receptor binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1902122", "pubmed": 10334992, "qualifier": "enables", "term": "chenodeoxycholic acid binding"}]}, "homologene": {"genes": [[7955, 436847], [8364, 100489310], [9031, 373902], [9544, 695618], [9598, 452162], [9606, 9971], [9615, 612928], [9913, 540528], [10090, 20186], [10116, 60351]], "id": 3760}, "interpro": [{"desc": "Nuclear hormone receptor, ligand-binding domain", "id": "IPR000536", "short_desc": "Nucl_hrmn_rcpt_lig-bd"}, {"desc": "Zinc finger, nuclear hormone receptor-type", "id": "IPR001628", "short_desc": "Znf_hrmn_rcpt"}, {"desc": "Nuclear hormone receptor", "id": "IPR001723", "short_desc": "Nuclear_hrmn_rcpt"}, {"desc": "Thyroid hormone receptor", "id": "IPR001728", "short_desc": "ThyrH_rcpt"}, {"desc": "Zinc finger, NHR/GATA-type", "id": "IPR013088", "short_desc": "Znf_NHR/GATA"}, {"desc": "Nuclear hormone receptor-like domain superfamily", "id": "IPR035500", "short_desc": "NHR-like_dom_sf"}, {"desc": "Bile acid receptor, ligand binding domain", "id": "IPR044114", "short_desc": "NR_LBD_NR1H4"}], "ipi": ["IPI00045302", "IPI00168867", "IPI00220798", "IPI00410346", "IPI01021708", "IPI01022446", "IPI01023023"], "map_location": "12q23.1", "name": "nuclear receptor subfamily 1 group H member 4", "other_names": ["RXR-interacting protein 14", "bile acid receptor", "farnesoid X nuclear receptor", "farnesoid X-activated receptor", "farnesol receptor HRR-1", "retinoid X receptor-interacting protein 14"], "pantherdb": {"HGNC": "7967", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1352464", "ortholog_type": "LDO", "panther_family": "PTHR24082", "taxid": 10090, "uniprot_kb": "Q60641"}, {"RGD": "628831", "ortholog_type": "LDO", "panther_family": "PTHR24082", "taxid": 10116, "uniprot_kb": "Q62735"}, {"Ensembl": "ENSGALG00000011594", "ortholog_type": "LDO", "panther_family": "PTHR24082", "taxid": 9031, "uniprot_kb": "Q8JHU2"}, {"ZFIN": "ZDB-GENE-080403-3", "ortholog_type": "O", "panther_family": "PTHR24082", "taxid": 7955, "uniprot_kb": "B0S5T9"}, {"ZFIN": "ZDB-GENE-040718-313", "ortholog_type": "LDO", "panther_family": "PTHR24082", "taxid": 7955, "uniprot_kb": "A0A2R8QR22"}, {"FlyBase": "FBgn0000546", "ortholog_type": "O", "panther_family": "PTHR24082", "taxid": 7227, "uniprot_kb": "P34021"}], "uniprot_kb": "Q96RI1"}, "pathway": {"kegg": {"id": "hsa04976", "name": "Bile secretion - Homo sapiens (human)"}, "pid": {"id": "rxr_vdr_pathway", "name": "RXR and RAR heterodimerization with other nuclear receptor"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-159418", "name": "Recycling of bile acids and salts"}, {"id": "R-HSA-192105", "name": "Synthesis of bile acids and bile salts"}, {"id": "R-HSA-193368", "name": "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}, {"id": "R-HSA-193807", "name": "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"}, {"id": "R-HSA-194068", "name": "Bile acid and bile salt metabolism"}, {"id": "R-HSA-1989781", "name": "PPARA activates gene expression"}, {"id": "R-HSA-211859", "name": "Biological oxidations"}, {"id": "R-HSA-211897", "name": "Cytochrome P450 - arranged by substrate type"}, {"id": "R-HSA-211945", "name": "Phase I - Functionalization of compounds"}, {"id": "R-HSA-211976", "name": "Endogenous sterols"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-2990846", "name": "SUMOylation"}, {"id": "R-HSA-3108232", "name": "SUMO E3 ligases SUMOylate target proteins"}, {"id": "R-HSA-383280", "name": "Nuclear Receptor transcription pathway"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-400206", "name": "Regulation of lipid metabolism by PPARalpha"}, {"id": "R-HSA-4090294", "name": "SUMOylation of intracellular receptors"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-8957322", "name": "Metabolism of steroids"}], "wikipathways": [{"id": "WP2289", "name": "Drug Induction of Bile Acid Pathway"}, {"id": "WP2879", "name": "Farnesoid X receptor pathway"}, {"id": "WP2882", "name": "Nuclear Receptors Meta-Pathway"}, {"id": "WP299", "name": "Nuclear Receptors in Lipid Metabolism and Toxicity"}, {"id": "WP4396", "name": "Nonalcoholic fatty liver disease"}]}, "pdb": ["1OSH", "3BEJ", "3DCT", "3DCU", "3FLI", "3FXV", "3GD2", "3HC5", "3HC6", "3L1B", "3OKH", "3OKI", "3OLF", "3OMK", "3OMM", "3OOF", "3OOK", "3P88", "3P89", "3RUT", "3RUU", "3RVF", "4OIV", "4QE8", "4WVD", "5IAW", "5ICK", "5Q0I", "5Q0J", "5Q0K", "5Q0L", "5Q0M", "5Q0N", "5Q0O", "5Q0P", "5Q0Q", "5Q0R", "5Q0S", "5Q0T", "5Q0U", "5Q0V", "5Q0W", "5Q0X", "5Q0Y", "5Q0Z", "5Q10", "5Q11", "5Q12", "5Q13", "5Q14", "5Q15", "5Q16", "5Q17", "5Q18", "5Q19", "5Q1A", "5Q1B", "5Q1C", "5Q1D", "5Q1E", "5Q1F", "5Q1G", "5Q1H", "5Q1I", "5WZX", "5Y1J", "5Y44", "5Y49", "5YXB", "5YXD", "5YXJ", "5YXL", "5Z12", "6A5W", "6A5X", "6A5Y", "6A5Z", "6A60", "6HL0", "6HL1", "6ITM", "7D42", "7TRB", "7VUE", "8HBM", "8HD3"], "pfam": ["PF00104", "PF00105"], "pharmgkb": "PA31752", "pharos": {"target_id": 835, "tdl": "Tclin"}, "prosite": ["PS51030", "PS51843"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF260819", "relationship": "is"}, {"id": "GNF260820", "relationship": "is"}, {"id": "GNF260821", "relationship": "is"}, {"id": "GNF260822", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF039259", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF086730", "relationship": "is"}, {"id": "GNF086731", "relationship": "is"}, {"id": "GNF086732", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051081", "relationship": "is"}, {"id": "GNF055848", "relationship": "is"}, {"id": "GNF060537", "relationship": "is"}, {"id": "GNF078770", "relationship": "is"}, {"id": "GNF078771", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF069181", "relationship": "is"}, {"id": "GNF069182", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF094078", "relationship": "is"}, {"id": "GNF133736", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000012.12", "NC_060936.1", "NG_029843.1"], "protein": ["NP_001193906.1", "NP_001193907.1", "NP_001193908.1", "NP_001193921.1", "NP_001193922.1", "NP_005114.1", "XP_006719782.1", "XP_011537342.1", "XP_011537343.1", "XP_047285899.1", "XP_047285900.1", "XP_054229928.1", "XP_054229929.1", "XP_054229930.1", "XP_054229931.1", "XP_054229932.1"], "rna": ["NM_001206977.2", "NM_001206978.2", "NM_001206979.2", "NM_001206992.2", "NM_001206993.2", "NM_005123.4", "NR_135146.2", "XM_006719719.3", "XM_011539040.3", "XM_011539041.3", "XM_047429943.1", "XM_047429944.1", "XM_054373953.1", "XM_054373954.1", "XM_054373955.1", "XM_054373956.1", "XM_054373957.1"], "translation": [{"protein": "XP_054229930.1", "rna": "XM_054373955.1"}, {"protein": "NP_001193922.1", "rna": "NM_001206993.2"}, {"protein": "XP_006719782.1", "rna": "XM_006719719.3"}, {"protein": "XP_054229929.1", "rna": "XM_054373954.1"}, {"protein": "NP_001193921.1", "rna": "NM_001206992.2"}, {"protein": "XP_047285900.1", "rna": "XM_047429944.1"}, {"protein": "XP_011537343.1", "rna": "XM_011539041.3"}, {"protein": "XP_054229931.1", "rna": "XM_054373956.1"}, {"protein": "XP_047285899.1", "rna": "XM_047429943.1"}, {"protein": "NP_001193908.1", "rna": "NM_001206979.2"}, {"protein": "XP_054229932.1", "rna": "XM_054373957.1"}, {"protein": "XP_011537342.1", "rna": "XM_011539040.3"}, {"protein": "XP_054229928.1", "rna": "XM_054373953.1"}, {"protein": "NP_001193907.1", "rna": "NM_001206978.2"}, {"protein": "NP_005114.1", "rna": "NM_005123.4"}, {"protein": "NP_001193906.1", "rna": "NM_001206977.2"}]}, "reporter": {"HG-U133_Plus_2": ["1554375_a_at", "206340_at", "243800_at"], "HG-U95Av2": "38519_at", "HTA-2_0": "TC12000778.hg.1", "HuEx-1_0": "3428225", "HuGene-1_1": "7957835", "HuGene-2_1": "16755671"}, "summary": "This gene encodes a ligand-activated transcription factor that shares structural features in common with nuclear hormone receptor family members. This protein functions as a receptor for bile acids, and when bound to bile acids, binds to DNA and regulates the expression of genes involved in bile acid synthesis and transport. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Feb 2016].", "symbol": "NR1H4", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1417825"}, "unigene": ["Hs.732506", "Hs.282735"], "uniprot": {"Swiss-Prot": "Q96RI1", "TrEMBL": ["F1DAL1", "B6ZGS9", "F8W1M1", "F8W656", "G8JLB0", "H0YHD5"]}, "wikipedia": {"url_stub": "Farnesoid X receptor"}}